SCHAUMBURG, Ill.--(BUSINESS WIRE)--Sparton Corporation (NYSE:SPA) has been chosen by PathoGenetix, Inc. as the design and manufacturing partner for their RESOLUTION™ Microbial Genotyping System. PathoGenetix, is a developer of an automated system for rapid bacterial strain typing. Under the terms of the agreement, Sparton will conduct design for manufacture and pilot production of a limited number of pre-commercial instruments for the RESOLUTION System, which is slated for commercial availability in late 2014.
Help employers find you! Check out all the jobs and post your resume.
